1. Home
  2. INBX
  3. INBX News

Latest Inhibrx Inc. (INBX) News on July 27, 2024

INBX

MT Newswires

2 months ago

Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing

INBX

MT Newswires

2 months ago

Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
INBX

PR Newswire

2 months ago

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
INBX

PR Newswire

3 months ago

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
INBX

PR Newswire

3 months ago

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
INBX

Zacks

5 months ago

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
INBX

PR Newswire

5 months ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
INBX

Zacks

6 months ago

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
INBX

Barrons.com

6 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
INBX

GlobeNewswire

6 months ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead
INBX

Motley Fool

6 months ago

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript
INBX

Insider Monkey

6 months ago

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
INBX

Zacks

6 months ago

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41
INBX

Simply Wall St.

6 months ago

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
INBX

Zacks

6 months ago

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?
INBX

Zacks

6 months ago

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?

Health Care Roundup: Market Talk
INBX

The Wall Street Journal

6 months ago

Health Care Roundup: Market Talk

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More
INBX

Barrons.com

6 months ago

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
INBX

Investor's Business Daily

6 months ago

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
INBX

Zacks

6 months ago

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months
INBX

Business Wire

6 months ago

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months

Sanofi to buy Inhibrx in deal worth up to $2.2B
INBX

BioPharma Dive

6 months ago

Sanofi to buy Inhibrx in deal worth up to $2.2B

Is CNO Financial Group (CNO) Stock Undervalued Right Now?
INBX

Zacks

6 months ago

Is CNO Financial Group (CNO) Stock Undervalued Right Now?

Crinetics Pharmaceuticals Inc Insider Sells Shares
INBX

GuruFocus.com

6 months ago

Crinetics Pharmaceuticals Inc Insider Sells Shares

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE
INBX

Simply Wall St.

7 months ago

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know
INBX

Zacks

7 months ago

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note
INBX

Zacks

7 months ago

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note

SiTime to Present at the Needham Growth Conference on January 16, 2024
INBX

GlobeNewswire

7 months ago

SiTime to Present at the Needham Growth Conference on January 16, 2024

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?
INBX

Simply Wall St.

7 months ago

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?

Is Array Technologies Stock a Top Buy on the Dip in 2024?
INBX

Motley Fool

7 months ago

Is Array Technologies Stock a Top Buy on the Dip in 2024?

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?
INBX

Simply Wall St.

8 months ago

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote
INBX

GlobeNewswire

8 months ago

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
INBX

Zacks

9 months ago

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023
INBX

Business Wire

9 months ago

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable
INBX

Simply Wall St.

9 months ago

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable

Share on Social Networks: